Amendment and Restatement to AgreementsAsset Purchase Agreement and License Agreement • November 3rd, 2022 • XOMA Corp • Pharmaceutical preparations
Contract Type FiledNovember 3rd, 2022 Company IndustryThis Amendment and Restatement (“Amendment”) to both the Asset Purchase Agreement (“APA”) and Nanotherapeutics License Agreement (“License Agreement”) is dated February 2, 2017, between XOMA Corporation (“XOMA”) and Nanotherapeutics, Inc. (“Nano”). Capitalized terms not otherwise defined in this Amendment shall have the meaning set forth in the APA and License Agreement.
Amendment and Restatement to AgreementsAsset Purchase Agreement and License Agreement • November 6th, 2017 • XOMA Corp • Pharmaceutical preparations
Contract Type FiledNovember 6th, 2017 Company IndustryThis Amendment and Restatement (“Amendment”) to both the Asset Purchase Agreement (“APA”) and Nanotherapeutics License Agreement (“License Agreement”) is dated February 2, 2017, between XOMA Corporation (“XOMA”) and Nanotherapeutics, Inc. (“Nano”). Capitalized terms not otherwise defined in this Amendment shall have the meaning set forth in the APA and License Agreement.